{
  "company": {
    "name": "CPTx Bio",
    "website": "https://cptx.bio/",
    "record": "https://startuphistory.org/c/cptx.bio"
  },
  "status": null,
  "history_since": "2024-04-22T10:57:30.000Z",
  "baseline": {
    "snapshot_id": "ab9f3a756354c5111d5c7dd80317f04569c27ecdd753b74c0f1d9fc894d62e69",
    "observed_at": "2024-04-22T10:57:30.000Z",
    "headline": "Pioneering Composite Programmable Therapeutics",
    "description": "At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases.The flexibility and precision of CPTx's platform support multivalent drug deve",
    "evidence": "https://web.archive.org/web/20240422105730/https://www.cptx.bio/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T13:03:59.529Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2025-01-08T18:33:56.000Z",
      "variants": [
        {
          "headline": "Pioneering Composite Programmable Therapeutics",
          "subhead": "At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases.The flexibility and precision of CPTx's platform support multivalent drug deve",
          "observed_at": "2024-04-22T10:57:30.000Z",
          "evidence": "https://web.archive.org/web/20240422105730/https://www.cptx.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Pioneering Composite Programmable Therapeutics",
          "subhead": "At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug",
          "observed_at": "2024-08-02T09:52:50.000Z",
          "evidence": "https://web.archive.org/web/20240802095250/https://www.cptx.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Engineering the future of medicine with composite programmable therapeutics.",
          "subhead": "At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug",
          "observed_at": "2025-01-08T18:33:56.000Z",
          "evidence": "https://web.archive.org/web/20250108183356/https://www.cptx.bio/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Engineering the future of medicine with composite programmable therapeutics.",
      "subhead": "At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug",
      "from": "2024-04-22T10:57:30.000Z",
      "to": "2025-01-08T18:33:56.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20250108183356/https://www.cptx.bio/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-04-22T10:57:30.000Z",
          "to": "2025-01-08T18:33:56.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-07-14T05:41:46.000Z",
      "variants": [
        {
          "headline": "Breakthroughs start with single strands.",
          "subhead": "At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug",
          "observed_at": "2025-07-14T05:41:46.000Z",
          "evidence": "https://web.archive.org/web/20250714054146/https://www.cptx.bio/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Breakthroughs start with single strands.",
      "subhead": "At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug",
      "from": "2025-07-14T05:41:46.000Z",
      "to": "2025-07-14T05:41:46.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20250714054146/https://www.cptx.bio/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2025-07-14T05:41:46.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T13:03:59.529Z",
      "variants": [
        {
          "headline": "The future of CAR-T is in vivo… powered by DNA.",
          "subhead": null,
          "observed_at": "2026-01-15T14:54:11.000Z",
          "evidence": "https://web.archive.org/web/20260115145411/https://cptx.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The future of CAR-T is in vivo… powered by DNA.",
          "subhead": null,
          "observed_at": "2026-07-10T13:15:27.000Z",
          "evidence": "https://web.archive.org/web/20260710131527/https://cptx.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The future of CAR-T is in vivo… powered by DNA.",
          "subhead": null,
          "observed_at": "2026-07-12T05:58:22.000Z",
          "evidence": "https://web.archive.org/web/20260712055822/https://cptx.bio/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "The future of CAR-T is in vivo… powered by DNA.",
          "subhead": null,
          "observed_at": "2026-11-05T13:03:59.529Z",
          "evidence": "https://cptx.bio/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "The future of CAR-T is in vivo… powered by DNA.",
      "subhead": null,
      "from": "2026-01-15T14:54:11.000Z",
      "to": "2026-11-05T13:03:59.529Z",
      "captures": 4,
      "evidence": "https://cptx.bio/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-01-15T14:54:11.000Z",
          "to": "2026-11-05T13:03:59.529Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-cadc7be80ee3677660dfc797e8e80229b8017b012d1fbcfa2fece082c8dd50b2:50c1edfd445fb7d55fb11190b573470e1d1ffb1705f0c92096b53913b4ff605f:headline:a1270d1da6dbef16",
      "before_evidence": "https://web.archive.org/web/20240802095250/https://www.cptx.bio/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Pioneering Composite Programmable Therapeutics” to “Engineering the future of medicine with composite programmable therapeutics.”.",
      "between": {
        "from": "2024-08-02T09:52:50.000Z",
        "to": "2025-01-08T18:33:56.000Z"
      },
      "evidence": "https://web.archive.org/web/20250108183356/https://www.cptx.bio/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "classifier-50c1edfd445fb7d55fb11190b573470e1d1ffb1705f0c92096b53913b4ff605f:335a281e77abc203c3177ac070dc92af2e02c365736e33cba3a8f8a5f1751369:repositioning",
      "before_evidence": "https://web.archive.org/web/20250108183356/https://www.cptx.bio/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “Engineering the future of medicine with composite programmable therapeutics.” to “Breakthroughs start with single strands.”. A classifier read this as a change in its core product.",
      "between": {
        "from": "2025-01-08T18:33:56.000Z",
        "to": "2025-07-14T05:41:46.000Z"
      },
      "evidence": "https://web.archive.org/web/20250714054146/https://www.cptx.bio/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    },
    {
      "n": 3,
      "id": "page-335a281e77abc203c3177ac070dc92af2e02c365736e33cba3a8f8a5f1751369:b76723604adf2680abd6183a8c28fe871405af0aaa0c19d0898b81d85e9958a2:headline:116fa92297ae1417",
      "before_evidence": "https://web.archive.org/web/20250714054146/https://www.cptx.bio/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Breakthroughs start with single strands.” to “The future of CAR-T is in vivo… powered by DNA.”.",
      "between": {
        "from": "2025-07-14T05:41:46.000Z",
        "to": "2026-01-15T14:54:11.000Z"
      },
      "evidence": "https://web.archive.org/web/20260115145411/https://cptx.bio/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “CPTx Bio” company record, https://startuphistory.org/c/cptx.bio"
}